BioCentury
ARTICLE | Company News

Astellas' ipragliflozin approved in Japan

January 18, 2014 2:17 AM UTC

Astellas Pharma Inc. (Tokyo:4503) said Japan's Ministry of Health, Labor and Welfare (MHLW) approved an NDA for Suglat ipragliflozin to treat Type II diabetes -- the first sodium-glucose cotransporter...